Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Arcadia Biosciences (RKDA) Announces CFO Transition

PR Newswire - Wed Nov 30, 2022

-- Pam Haley to be replaced by Thomas J. Schaefer effective January 3, 2023 --

DAVIS, Calif., Nov. 30, 2022 /PRNewswire/ -- Arcadia Biosciences, Inc.® (NASDAQ: RKDA), a producer and marketer of innovative, plant-based health and wellness products, announced that CFO Pam Haley will be leaving the company and will be replaced by Thomas J. Schaefer, effective January 3, 2023. Schaefer is currently Arcadia's vice president of finance and investor relations. Haley will remain in an advisory role to support the transition.

Read more at prnewswire.com

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).